Patient Group Surveys for Corporate Reputation of Pharma in 2018-19
Study: Comparing the extent to which the pharma industry—and pharma companies—met the expectations of patient organisations (and took their views into consideration) during 2018
LINKS TO THE ONLINE SURVEY IN 18 LANGUAGES:
- 中文: http://createsend.com/t/j-A6F7B6F52E82C06E2540EF23F30FEDED
- 한국어: http://createsend.com/t/j-697AB637A76115962540EF23F30FEDED
- 日本語: http://createsend.com/t/j-63BBE58CDDA7D61E2540EF23F30FEDED
- Dansk: http://createsend.com/t/j-65F32E2AC09A70472540EF23F30FEDED
- Deutsch: http://createsend.com/t/j-7C79FA79D7E588C02540EF23F30FEDED
- Ελληνικά: http://createsend.com/t/j-E174B7AE76685F792540EF23F30FEDED
- English: http://createsend.com/t/j-F40364024EE10E5D2540EF23F30FEDED
- Español: http://createsend.com/t/j-1E2868539968B5A52540EF23F30FEDED
- Français: http://createsend.com/t/j-50B17EC5DDBD19382540EF23F30FEDED
- Italiano: http://createsend.com/t/j-2E584325448539212540EF23F30FEDED
- Magyar: http://createsend.com/t/j-E97FEF0111BB13B82540EF23F30FEDED
- Nederlands: http://createsend.com/t/j-47D87C53BE538D292540EF23F30FEDED
- Polski: http://createsend.com/t/j-77F9F29CC1D609F62540EF23F30FEDED
- Portugues: http://createsend.com/t/j-99E5E7B5A4A94BC32540EF23F30FEDED
- русский: http://createsend.com/t/j-8D99CFA41AC3D7F22540EF23F30FEDED
- Suomalainen: http://createsend.com/t/j-DC3559BC2CBCA57C2540EF23F30FEDED
- Svenska: http://createsend.com/t/j-6C4FF35889F073BE2540EF23F30FEDED
- Türk: http://createsend.com/t/j-A3ABC186838C97EB2540EF23F30FEDED
WHY WE NEED YOUR HELP
As an active, leading, patient-group representative, your opinion is very important—particularly on how pharma can improve its patient centricity.
Should you know any other patient groups that you think might also wish to offer their opinions to the 2018 study, please feel free to circulate this email to them.
ABOUT THIS STUDY
- The questionnaire is being carried on a specialist survey website, so allowing all responses to be completely anonymous (unless you wish otherwise).
- To thank you for participating, PatientView will provide your organisation with the full final report upon publication (March/April 2019), if you would like to receive it.
- The study is conducted entirely independently. No pharmaceutical funding is involved. PatientView funds the whole exercise itself by selling final reports to industry, and to government and regulatory bodies.
To be sure that your response is made in time, please complete before the study’s closing date of 23rd February 2019
If you have any questions, please contact Dr Alexandra Wyke: email@example.com
Do give us your opinion …